Document is current
Any future updates will be listed below
-
Authors
Woodie, Brad R. https://orcid.org/0000-0002-7481-5216
Holt, Isaiah N.
Freking, Justin A.
Harrison, Heather C. W.
Rivin, Gabrielle M.
Fleischer Jr, Alan B.
- License Information
-
More Information
Article History
Received: 3 January 2025
Revised: 15 February 2025
Accepted: 25 February 2025
First Online: 19 March 2025
Declarations
:
: This study was deemed exempt by the University of Cincinnati College of Medicine Institutional Review Board.
: As research has been deemed as non-human subject research.
: Alan Fleischer is a consultant for Bluefin and Incyte (fees). He is an investigator for Amgen, Bayer, Biogen, CellDex, Galderma, Incyte, Leo, and UCB (research support). He is a speaker for Imedic Healthcare Solutions (Hyderabad, India). Brad Woodie, Justin Freking, Isaiah Holt, Heather Harrison, and Gabrielle Rivin declare that they have no conflict of interest.
